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The novel immune-type receptors (NITRs), which have been described in numerous bony fish species, are encoded by multigene
families of inhibitory and activating receptors and are predicted to be functional orthologs to the mammalian natural killer cell
receptors (NKRs). Within the zebrafish NITR family, nitr9 is the only gene predicted to encode an activating receptor. However,
alternative RNA splicing generates three distinct nitr9 transcripts, each of which encodes a different isoform. Although nitr9
transcripts have been detected in zebrafish lymphocytes, the specific hematopoietic lineage(s) that expresses Nitr9 remains to
be determined. In an effort to better understand the role of NITRs in zebrafish immunity, anti-Nitr9 monoclonal antibodies were
generated and evaluated for the ability to recognize the three Nitr9 isoforms. The application of these antibodies to flow cytometry
should prove to be useful for identifying the specific lymphocyte lineages that express Nitr9 and may permit the isolation of
Nitr9-expressing cells that can be directly assessed for cytotoxic (e.g., NK) function.
1. Introduction
Mammalian natural killer (NK) cells are large, granular
lymphocytes of the innate immune system that express
several cell surface receptors to regulate cytotoxic function
through a complex network of signaling pathways. NK cell
receptors include both activating and inhibitory forms that
are proficient in distinguishing neoplastic or virally infected
cells from normal host cells [1, 2]. The regulation of NK
cell cytotoxicity is dependent on the integration of signals
from activating and inhibitory receptors [3]. Although it is
postulated that NK cell receptors arose early in vertebrate
phylogeny, functional data are based primarily on studies of
mammalian NK cell receptors [4].
In order to appreciate the origins and evolution of NK
cell receptors and their function, it is critical to define
equivalent receptor forms in nonmammalian species. The
bony fish represent one of the earliest vertebrate lineages
with a functional innate and adaptive immune response that
closely parallels that of humans and other mammals [5].
A large multigene family of recently and rapidly evolving
inhibitory and activating novel immune-type receptors
(NITRs) that share structural and functional characteristics
with mammalian NK cell receptors has been identified in
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multiple fish species [6, 7]. Complete analyses of the NITR
gene clusters at the sequence level only have been performed
with the zebrafish and medaka genomes [8–11]. Although
transcripts of various catfish NITRs have been detected in
NK-like, T, B, and macrophage cell lines [12], transcripts
of all zebrafish NITRs are detectable in the lymphoid, but
not the myeloid, lineage [13]. Of the 39 NITR genes that
have been identified within the zebrafish genome, nitr9 is
the only NITR gene that is predicted to encode an activating
receptor [10, 11, 14]. Three alternatively spliced transcripts
of nitr9 have been characterized: Nitr9-long (Nitr9L), Nitr9-
short (Nitr9S), and Nitr9-supershort (Nitr9SS), which differ
in their extracellular domains [13, 14]. Nitr9L is the most
similar to other NITRs in that it possesses two extracellular
Ig domains: one of the variable (V) type and one of the
intermediate (I) type [6]. Nitr9S arises through cryptic splice
donor and acceptor sites within the exon encoding the
V domain. Nitr9SS lacks the entire V domain exon. The
transmembrane domain of all Nitr9 isoforms possesses a
positively charged residue: this feature permits Nitr9L to
associate with and signal through the adaptor protein Dap12
[14]. Based on protein structures, Nitr9S and Nitr9SS also
are expected to signal via Dap12; however, this has not been
verified experimentally.
Although nitr9 transcripts have been detected in
zebrafish lymphocytes, the identification and recovery of
Nitr9-expressing cells has not been possible. Herein we
describe the derivation of two anti-Nitr9 monoclonal anti-
bodies, demonstrate their utility to recognize recombinant
Nitr9 by indirect immunofluorescence, flow cytometry, and
Western blot analyses, and subsequently identify all three
Nitr9 isoforms in zebrafish tissues by Western blot analyses.
These antibodies should prove useful for: (1) evaluating
Nitr9 protein levels within tissues by Western blot, (2)
evaluating the distribution of Nitr9 expressing cells within
tissues by indirect immunofluorescence, (3) defining the
specific hematopoietic lineage(s) that express Nitr9 by flow
cytometry, and (4) purifying Nitr9 expressing cells by
fluorescence-activated cell sorting (FACS) for functional
characterization.
2. Materials andMethods
2.1. Zebrafish. All experiments involving live zebrafish
(Danio rerio) were performed in accordance with relevant
institutional and national guidelines and regulations and
were approved by the North Carolina State University Insti-
tutional Animal Care and Use Committee. Adult zebrafish
(EkkWill Waterlife Resources, Ruskin, FL) were maintained
and sacrificed as described [15].
2.2. Reverse Transcriptase-PCR. Total RNA from dissected
zebrafish tissues (2 μg) was reverse transcribed (SuperScript
III Reverse Transcriptase, Life Technologies, Carlsbad, CA),
and cDNAs were subjected to thermal cycling with gene-
specific primers (Table 1) and Titanium Taq DNA poly-
merase (Clontech,Mountain View, CA). The number of PCR
cycles used for detecting nitr9 and β-actin (both annealing at
65◦C) was 40 and 25, respectively.
Lymphoid and myeloid cell populations were purified
from the kidney of multiple zebrafish and pooled as
described [16]. Total RNA from isolated cells (1 μg) was
reverse transcribed (SuperScript III Reverse Transcriptase).
cDNAs from tissues and isolated cells were subjected to
quantitative PCR (Q-PCR) with TaqMan primers and probes
(Life Technologies, Carlsbad, CA) (Table 1). Q-PCR was
performed on a single-color MyiQ real-time PCR detection
system (Bio-Rad, Hercules, CA) using the protocol: 50◦C for
2min, 95◦C for 10min, followed by 55 cycles at 95◦C for 15 s
and at 60◦C for 1min. The threshold cycle (CT) value was
calculated by the iQ5 Optical System Software (Bio-Rad).
Relative transcript levels of nitr9 were normalized to β-actin
and calculated using the 2−ΔΔCT method [17]. All reactions
were carried out as technical triplicates.
2.3. Antibody Development and Purification. The coding
sequence of the Nitr9 I domain (nucleotides 298–623 of
GenBank NM 001005576.1) was amplified by PCR (Table 1)
and cloned into pETBlue-1 (EMD Millipore, Billerica, MA),
and E. coli Tuner cells (EMD Millipore) were transformed
employing a standard procedure. Cells were induced, and the
Nitr9 I domain was recovered from inclusion bodies.
Swiss Webster mice were immunized with the Nitr9 I
domain expressed in E. coli and splenocytes were fused
with P3X63Ag8.653 cells (CRL-1580, ATCC, Manassas, VA).
Approximately 3,000 individual hybridoma supernatants
were screened by an enzyme-linked immunosorbent assay
(ELISA) against the denatured recombinant Nitr9 I domain
(Immunology Core Facility, University of North Carolina,
Chapel Hill). The most strongly reactive ∼100 supernatants
in turn were screened by parallel Western blot analyses
and indirect immunofluorescence. Two single clones, 19.1.1
(herein referred to as anti-Nitr919) and 90.10.5 (herein
referred to as anti-Nitr990), were selected for additional char-
acterization based on their ability to recognize recombinant
Nitr9. Antibody isotypes were determined (IsoStrips: Roche;
Indianapolis, IN) to be IgG2b, κ light chain (90.10.5), and
IgG2a, κ light chain (19.1.1). Antibodies were purified via
protein A agarose columns (Upstate Cell Signaling Solutions;
Lake Placid, NY).
2.4. Plasmids and Cell Culture. Nitr9 expression cassettes
(without epitope tags) were constructed with pcDNA3 (Life
Technologies). Epitope (FLAG)-tagged Nitr9 (FLAG-Nitr9)
expression cassettes were constructed with the pLF plasmid
which incorporates an amino-terminal leader sequence and
FLAG epitope [14]. The coding sequences of zebrafish
nitr9L, nitr9S, and nitr9SS were amplified by PCR and
cloned into pcDNA3 or pLF. Nitr9 and FLAG-Nitr9 cas-
settes were then shuttled into pIRES2-EGFP (Clontech)
generating: pNitr9L/EGFP, pNitr9S/EGFP, pNitr9SS/EGFP,
pFLAG-Nitr9L/EGFP, pFLAG-Nitr9S/EGFP, and pFLAG-
Nitr9SS/EGFP plasmids (Figure 1). Primer sequences that
were used in cloning steps are included in Table 1. Plasmids
were transfected into human HEK293T cells using Fugene
6 (Roche) according to the manufacturer’s instructions and
were harvested 48 hr after transfection.
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Table 1: Oligonucleotide primer sequences.
Purpose Primer sequence
Reverse transcriptase—PCR: nitr9
GGATTTTTGGACTTTTCTGTC
TCCACATGCGGTAACTGTAC
Reverse transcriptase—PCR: β-actin
GGTATGGAATCTTGCGGTATCCAC
ATGGGCCAGACTCATCGTACTCCT
TaqMan Q-PCR: nitr9 (probe = CAAGGTTTGGAAAAGCAC)
GTCAAAGGGACAAGGCTGATAGTT
GTTCAAAACAGTGCATGTAAGACTCA
TaqMan Q-PCR: β-actin (probe = CCCATGCCATCCTGC)
CCATCTATGAGGGTTACGCTCTTC
AGGATCTTCATCAGGTAGTCTGTCA
Amplify nitr9 I domain for bacterial expression construct
ATGGAAAAGCACACTGTAGTAa
TTATTTAGAGCCATTCCTGTCCb
Amplify nitr9L for FLAG-tagged expression cassette
CACCCAAATGCACCACCTGTGTTTGTTAAACc
gactgcggccgcTTACTGCTGGTTAGAAACd
Amplify nitr9S for FLAG-tagged expression cassette
CACCCAAATGCACCACCTGTGc
gactgcggccgcTTACTGCTGGTTAGAAACd
Amplify nitr9SS for FLAG-tagged expression cassette
CATGATTTAATTCCATCCCAc
gactgcggccgcTTACTGCTGGTTAGAAACd
Amplify wild type nitr9L, nitr9S and nitr9SS for expression cassettes
gatcggatccgacATGATCAACTTTTGGATTTe
gatcgaattcTTACTGCTGGTTAGAAACCGAGf
aAn artificial start codon is underlined.
bAn artificial stop codon is bold.
cThese primers are designed for blunt PCR cloning into the EcoRV site of pLF.
dOverhang (5′) sequences are in lower case text and include a Not I site for cloning into pLF.
eOverhang (5′) sequences are in lower case text and include a BamHI site for cloning into pcDNA3.
fOverhang (3′) sequences are in lower case text and include an EcoRI site for cloning into pcDNA3.
2.5. Indirect Immunofluorescence. HEK293T cells were trans-
fected in four well chamber slides (Thermo Fisher Scientific,
Rochester, NY). Transfected cells were washed in phosphate
buffered saline (PBS), fixed with 3% paraformaldehyde for
20min and treated with 50mM NH4Cl, PBS for 5 minutes.
Cells were then permeabilized with 1.0% Triton-X-100 in
PBS for 5min, rinsed and blocked with 1% BSA in PBS
for 5min. Permeabilized cells were incubated with the anti-
Nitr919, anti-Nitr990, or anti-FLAG antibody for 1 hr, rinsed
with PBS, incubated with a phycoerythrin (PE) anti-mouse
IgG antibody and DAPI (1 : 1000) for 1 hr, and washed
with PBS. Chambers were removed from the slides, and
coverslips were mounted using immunomount (Thermo
Shandon, Pittsburgh, PA). Cells were photographed at 40x
magnification using a Leica DM5000 microscope.
2.6. Flow Cytometry. Transfected HEK293T cells were incu-
bated with the anti-Nitr919, anti-Nitr990, or anti-FLAG
monoclonal antibody for 1 hr, washed in PBS, and incubated
for 30minwith an allophycocyanin- (APC-) conjugated anti-
mouse IgG secondary antibody. Labeled cells were washed
and then fixed with 3% paraformaldehyde and subjected to
flow cytometric analysis (BD FACSCalibur, BD Biosciences,
San Jose, CA).
2.7. Western Analyses. Transfected HEK293T cells were
washed with PBS and lysed with mammalian protein
extraction reagent (M-PER, Pierce, Rockford, IL). Kidney,
spleen, intestine, and gills were removed from sacrificed
adult zebrafish and collected directly into tissue protein
extraction reagent (T-PER, Pierce) supplemented with pro-
tease inhibitors (Pierce) and homogenized. Lysates were cen-
trifuged to remove nuclei, and cell debris and protein con-
centrations were determined (BCA Protein Assay, Pierce).
Proteins were resolved on 12% SDS-polyacrylamide gels and
transferred to polyvinylidene difluoride (PVDF) membranes
for Western analyses. Membranes were washed in Tris-
buffered saline with 0.1% Tween 20 (TBST) and incubated
in blocking buffer (100mM boric acid, 25mM Na-Borate,
75mM NaCl, 5% goat serum, and 5% dry milk powder)
for 1 hr. Membranes were incubated overnight with primary
antibodies in blocking buffer at 4◦C. Primary antibodies
include anti-Nitr990, anti-FLAG (M2) mouse monoclonal
antibody (Sigma-Aldrich, St. Louis, MO), anti-GFP mouse
monoclonal antibody (Roche), and anti-GAPDH rabbit
polyclonal antibody (AnaSpec, Fremont, CA). Membranes
were washed in TBST, followed by incubation with blocking
buffer and either horseradish peroxidase-conjugated anti-
mouse IgG secondary antibody (Roche) or horseradish
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Figure 1: Transcriptional variation and expression of Nitr9. (a) Exon organization of the nitr9 gene depicting the three transcript
variants. Primer positions for PCR are indicated below. (b) The predicted Nitr9 protein isoforms encoded by the three nitr9 transcripts.
Transmembrane (TM) and immunoglobulin domains (of the variable (V) and intermediate (I) types) of Nitr9 are indicated. The I domain
of Nitr9 was used as the antigen for antibody production. The positive charge within the TM domain of Nitr9 is represented by a plus sign.
(c) RT-PCR with primers whose positions are depicted in (a) detects transcripts of all three nitr9 isoforms. (d) Quantitative RT-PCR with
nitr9 primers (Table 1), whose positions are depicted in (a), and a TaqMan probe that spans an exon-exon boundary reveal relative levels
of nitr9L/S transcripts in different tissues. (e) Schematic representation of the recombinant Nitr9 expression constructs used in this paper.
Constructs include an internal ribosomal entry sequence (IRES2) permitting the expression of two proteins from a single transcript.
peroxidase-conjugated anti-rabbit IgG secondary antibody
(Santa Cruz Biotechnology, Santa Cruz, CA). After washing
with TBST, the Lumi-LightPLUS western blotting substrate
and detection system (Roche) was used to visualize reactivity.
2.8. Endoglycosidase Treatment. Cleared lysates (20 μg) from
transfected cells were incubated with N-Glycosidase F
(PNGase F, New England Biolabs, Ipswich, MA) for 1 hr
at 37◦C. Cleared lysates (25 μg) from zebrafish tissues were
precipitated with OrgoSOL buffer (G-Biosciences, St. Louis,
MO) and resuspended in PNGase buffer for treatment with
PNGase F.
3. Results and Discussion
3.1. Nitr9 Isoforms. The genomic organization and predicted
protein structures of Nitr9L, Nitr9S, and Nitr9SS are shown
in Figures 1(a) and 1(b). All three isoforms are predicted to
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Figure 2: Detection of FLAG-tagged isoforms of Nitr9 from transfected cells by indirect immunofluorescence. HEK293T cells were
transfected with plasmids encoding FLAG-tagged Nitr9 isoforms and EGFP as indicated on top of the panels. FLAG-tagged Nitr9 proteins
were detected with (a) an anti-FLAG antibody, (b) anti-Nitr990 or (c) anti-Nitr919, and a PE conjugated secondary antibody (red). Transfected
cells can be identified by EGFP expression (green). DAPI labels the nuclei of all cells (blue). The pIRES2-EGFP parental plasmid was included
as a negative control.
encode type I transmembrane cell surface receptors that pos-
sess a positively charged residue within the transmembrane
domain. The nitr9S isoform is expressed at higher levels in
the zebrafish spleen, kidney, and intestine than the nitr9L and
nitr9SS isoforms, whereas, nitr9L transcripts are the most
abundant isoform expressed in gills. Transcripts of nitr9SS
are detected in all four tissues at reduced levels relative to the
other isoforms (Figure 1(c)). Q-PCR (Table 1) was employed
to determine the combined relative levels of nitr9L and
nitr9S transcripts in these same tissues as well as in purified
lymphoid and myeloid cells (the TaqMan primer/probe set
employed in this paper does not detect nitr9SS transcripts).
The combined relative expression level of nitr9L and nitr9S
transcripts is consistently higher in intestine than in kidney
and gill (Figure 1(d)). However, the relative expression level
of nitr9L and nitr9S in spleen varied between biological
replicates, ranging from levels matching those in intestine
to lower levels as observed in kidney and gill. As reported
previously, nitr9 transcripts are present at much higher
levels in zebrafish lymphocytes as compared to myeloid cells
[13]. In order to generate monoclonal antibodies that could
detect all three Nitr9 isoforms, mice were immunized with a
bacterially expressed Nitr9 I domain (see Figure 1(b)), and
hybridomas were screened for the production of antibodies
that recognize recombinant Nitr9 by ELISA, Western blot
and indirect immunofluorescence. Two clones, 19.1.1 (herein
referred to as anti-Nitr919) and 90.10.5 (herein referred to as
anti-Nitr990), were selected for further evaluation.
3.2. Detection of Nitr9 Isoforms in Transfected Cells by
Indirect Immunofluorescence. In order to determine if anti-
Nitr919 and anti-Nitr990 could detect all three isoforms of
Nitr9 by indirect immunofluorescence, HEK293T cells were
transfected with plasmids that coexpress EGFP and either a
FLAG-tagged or endogenous isoform of Nitr9; in this way,
any cell expressing Nitr9 also expresses EGFP (Figure 1(e)).
To ensure that the recombinant Nitr9 proteins could be
detected by immunofluorescence, an anti-FLAG antibody
was used to detect all three FLAG-tagged isoforms of Nitr9
in transfected cells (Figure 2(a)). It was then shown that
both anti-Nitr919 and anti-Nitr990 recognize FLAG-Nitr9L
and FLAG-Nitr9S by immunofluorescence, but either fail
to bind (anti-Nitr990) or bind less effectively (anti-Nitr919)
to FLAG-Nitr9SS (Figures 2(b) and 2(c)). In contrast, both
anti-Nitr919 and anti-Nitr990 effectively recognize all three
isoforms of endogenous Nitr9 when expressed in transfected
cells albeit with an apparent higher background labeling of
cells with anti-Nitr919 (Figure 3). It is possible that the FLAG-
tag disrupts folding of Nitr9SS or sterically interferes with
antibody recognition of the I domain of FLAG-Nitr9SS; this
also was observed with Western analyses (discussed below).
3.3. Detection of Nitr9 Isoforms in Transfected Cells by Flow
Cytometry. In order to determine if anti-Nitr919 and anti-
Nitr990 could detect all three isoforms of Nitr9 by flow
cytometry, HEK293T cells were transfected with plasmids
encoding an endogenous or FLAG-tagged isoform of Nitr9
6 Advances in Hematology
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Figure 3: Detection of endogenous isoforms of Nitr9 from transfected cells by indirect immunofluorescence. HEK293T cells were transfected
with plasmids encoding endogenous isoforms of Nitr9 and EGFP as indicated on top of the panels. Nitr9 proteins were detected with (a) anti-
Nitr990 or (b) anti-Nitr919 and a PE conjugated secondary antibody (red). Transfected cells can be identified by EGFP expression (green).
DAPI labels the nuclei of all cells (blue).
and EGFP (Figure 1(e)). Flow cytometry was performed
using the anti-FLAG, anti-Nitr919, and anti-Nitr990 anti-
bodies to detect Nitr9 expressing cells. The percentage of
double positive FLAG-Nitr9L expressing cells (i.e., EGFP+
and Nitr9+) was similar (55–63% of EGFP+ cells) when the
anti-FLAG or the anti-Nitr9 antibodies were employed (Fig-
ure 4(a)). Both anti-Nitr9 antibodies recognize transfected
cells expressing the endogenous isoform of Nitr9L with a
similar efficiency (61–73% of EGFP+ cells) (Figure 4(b)).
The anti-FLAG monoclonal antibody failed to bind
FLAG-Nitr9S and the anti-Nitr919 antibody failed to detect
the Nitr9S- or FLAG-Nitr9S-expressing cells (2–9% of
EGFP+ cells) (Figures 4(c) and 4(d)). Although the anti-
Nitr990 antibody detects FLAG-Nitr9S (31% of EGFP+ cells),
it does not recognize endogenous Nitr9S (∼5% of EGFP+
cells). Although the Nitr9S and FLAG-Nitr9S proteins are
produced by transfected cells (see Figures 2 and 3 and West-
ern blot results below) they may not be expressed effectively
on the cell surface. To determine if cell surface expression of
Nitr9S requires coexpression of the signaling adaptor protein
Dap12, cells were cotransfected with plasmids encoding
Nitr9S and zebrafish Dap12. No increase was observed in
cell surface labeling by the anti-Nitr9 antibodies (data not
shown).
The anti-FLAG and anti-Nitr919 antibodies effectively
bound FLAG-Nitr9SS (57% and 31% of EGFP+ cells, resp.).
The anti-Nitr990 antibody failed to bind FLAG-Nitr9SS, pos-
sibly due to steric hindrance by the FLAG tag (Figure 4(e))
since both anti-Nitr9 antibodies were effective at recognizing
Nitr9SS (65–75% of EGFP+ cells; Figure 4(f)).
3.4. Anti-Nitr990 Binds All Three Isoforms of Nitr9 in Western
Analyses. In order to evaluate the ability of the anti-Nitr990
antibody to detect the three isoforms of Nitr9 in Western
analyses, HEK293T cells were transfected with plasmids
encoding endogenous and FLAG-tagged isoforms of Nitr9
(Figure 1(e)). Cell lysates were subjected to Western blot
analyses using the anti-Nitr990 antibody. All three isoforms
of the endogenous Nitr9 as well as the FLAG-tagged Nitr9L
and Nitr9S proteins were detected. A binding pattern
equivalent to that seen with the anti-FLAG monoclonal
antibody positive control is apparent (Figure 5(a)). However,
anti-Nitr990 failed to bind the FLAG-tagged Nitr9SS. As
mentioned above, this may be a result of the FLAG-tag
blocking access to the specific epitope recognized by this
antibody.
Two proteins bands were detected by anti-Nitr990 in both
endogenous and FLAG-tagged Nitr9L and Nitr9S transfec-
tions that were also bound by the anti-FLAG antibody. Both
observed Nitr9L proteins migrated at a higher molecular
weight than the predicted size of Nitr9L (34 kD), and one of
the observed Nitr9S proteins was larger than the predicted
size of Nitr9S (30 kD). The differences are consistent with
differential glycosylation (see below). Based on the chemi-
luminescence exposure times required for detecting the
different isoforms of Nitr9, anti-Nitr990 appears to exhibit a
higher affinity for Nitr9L as compared to Nitr9S and Nitr9SS.
In parallel experiments, the anti-Nitr919 antibody did not
bind endogenous Nitr9S and Nitr9SS proteins (data not
shown) and was not characterized further in theWestern blot
analyses.
3.5. Nitr9 Glycosylation in Transfected Cells. Nitr9L, Nitr9S
and Nitr9SS possess three (NMSC, NDSR, and NGSK),
two (NMSC and NGSK), and one (NGSK) candidate N-
linked glycosylation sites, respectively. Treatment of lysates
from Nitr9 transfected cells with endoglycosidase (PNGase
F) results in the detection of only a single protein of
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Figure 4: Detection of Nitr9 isoforms by flow cytometry. HEK293T cells were transfected with plasmids encoding FLAG-tagged (a, c, and e)
or endogenous (b, d, and f) isoforms of Nitr9 and EGFP as indicated above the panels. Cells were labeled with an anti-FLAG antibody (top
row), anti-Nitr990 (middle row) or anti-Nitr919 (bottom row), and an APC conjugated secondary antibody. Flow cytometric analyses were
employed to detect EGFP positive (X axis) and APC positive (Y axis) cells. Isotype-matched antibodies were evaluated as controls for both
anti-Nitr9 antibodies and displayed no labeling of transfected cells (data not shown).
the expected size for both Nitr9L and Nitr9S (Figure 5(b)).
Both sets of results are consistent with in vivo glycosylation.
The observed size of Nitr9SS in transfected cells does not
appear to be altered by endoglycosidase treatment, with
the limitations of detection, suggesting that it may not be
glycosylated.
3.6. Nitr9 Proteins Are Differentially Expressed in Different
Tissues of Zebrafish. In order to determine if the anti-Nitr990
antibody can recognize endogenous Nitr9, lysates from adult
zebrafish tissues were treated with endoglycosidase and
subjected to Western blot analyses (Figure 5(c)). Nitr9L and
Nitr9S were detected at varying levels in the spleen, kidney,
gills, and intestine. Nitr9SS was detected only in the spleen,
although faint bands also have been observed in intestine
(data not shown). A nonspecific band of approximately
28 kD is detected in zebrafish tissues as well as in HEK293T
cells when the anti-Nitr990 antibody is used with large total
protein loads (e.g., 25 μg lysate; Figure 5(c)).
4. Conclusions
Three different transcript variants from nitr9, the single
putative activating NITR gene in zebrafish, and their
corresponding protein isoforms have been identified and
characterized. The utility of the anti-Nitr919 and anti-Nitr990
monoclonal antibodies for detecting recombinant Nitr9
was demonstrated by indirect immunofluorescence, flow
cytometry, and Western blot analyses. The antibodies exhibit
profound differences in recognizing the three different Nitr9
isoforms. When employed for indirect immunofluorescence,
both anti-Nitr9 antibodies bound efficiently and specifically
to cells-expressing all three Nitr9 isoforms. Both anti-Nitr9
antibodies are effective for detecting cell surface expression
of Nitr9L and Nitr9SS by flow cytometry. The anti-Nitr990
antibody recognized all three Nitr9 isoforms by Western blot
analyses, although a higher affinity for Nitr9L is noted. When
using anti-Nitr990 in Western blot analyses with high levels
of protein, a nonspecific band was identified. Although the
identity of this protein remains unknown, it may represent a
well-conserved member of the Ig superfamily.
Marked differences in the relative levels of Nitr9 tran-
scripts and protein isoforms are apparent. Although the
PCR analyses (Figure 1(c)) suggest that nitr9S may be
the predominant mRNA isoform in spleen, kidney, and
intestine, Western analyses demonstrate that Nitr9L is the
predominant protein isoform expressed in kidney. This
discrepancy may reflect differing transcript and protein
stability in different tissues or the preferred reactivity of the
antibody with Nitr9L (Figure 5(a)).
The monoclonal antibodies described here should be
useful for further evaluation of Nitr9 protein levels in
zebrafish tissues by Western blot analyses and identify-
ing Nitr9 expressing cells in tissue sections by indirect
immunofluorescence. Efforts are underway to purify Nitr9-
expressing zebrafish cells employing FACS in order to
characterize their morphology and cytotoxic properties.
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Figure 5: Detection of Nitr9 protein by Western analyses. (a) Western blot analyses of total protein lysates from HEK293T cells transiently
transfected with plasmids expressing a Nitr9 isoform and EGFP. Plasmids encode either an endogenous isoform of Nitr9 or a FLAG-tagged
Nitr9 as indicated above each lane. The primary antibodies utilized are shown on the left, and the molecular weights of identified bands are
shown on the right. The anti-FLAG antibody serves as a positive control for Nitr9 detection, and the anti-GFP antibody indicates transfection
efficiency of each plasmid. Note the total protein loaded (bottom) for the Nitr9L isoform is ten times less than that for Nitr9S and Nitr9SS
plasmids. Exposure times for chemiluminescence detection are indicated in each panel. (b) Nitr9L and Nitr9S are glycosylated. Western
blot analyses of endoglycosidase-treated total protein lysates from HEK293T cells that were transfected with plasmids encoding endogenous
Nitr9 isoforms. The anti-Nitr990 antibody recognizes all three Nitr9 isoforms at the predicted size (right). (c) Detection of Nitr9 protein from
zebrafish tissues. Western blot analyses of 25 μg of endoglycosidase-treated total protein from zebrafish tissues and HEK293T cells. Note that
a nonspecific band (∼28 kD) is detected in HEK293T cells as well as in zebrafish kidney and spleen, with high protein loads. Bottom panel
indicates loading control using an anti-GAPDH polyclonal antibody.
These antibodies may also prove to be useful for activating
(crosslinking) or blocking Nitr9 function in both cell culture
and ex-vivo functional assays as well as in dissecting isoform-
specific functions of NITRs.
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